Skip to main content
Have a personal or library account? Click to login
Prevalence and Impact of HIV Infections in Patients with Rheumatic Heart Disease: A Systematic Review and Meta-Analysis Cover

Prevalence and Impact of HIV Infections in Patients with Rheumatic Heart Disease: A Systematic Review and Meta-Analysis

Open Access
|Sep 2023

References

  1. Zühlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low- and middle-income countries. Circulation. 2016; 134(19): 14561466. DOI: 10.1161/CIRCULATIONAHA.116.024769
  2. Essop MR, Sa FCP, Lond F, Nkomo VT. Rheumatic and nonrheumatic valvular heart disease epidemiology, management, and prevention in Africa. Circulation. 2005; 112: 35843591. DOI: 10.1161/CIRCULATIONAHA.105.539775
  3. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. The Lancet. 2009; 373: 138294. DOI: 10.1016/S0140-6736(09)60692-9
  4. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet: Infectious Diseases. 2005; 5(11): 685694. DOI: 10.1016/S1473-3099(05)70267-X
  5. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. The Lancet. 2012; 379(9819): 953964. DOI: 10.1016/S0140-6736(11)61171-9
  6. Okello E, Kakande B, Sebatta E, Kayima J, Kuteesa M, Mutatina B, et al. Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda. In: Dasgupta K (ed). PLoS One. 2012; 7(8): e43917. DOI: 10.1371/journal.pone.0043917
  7. Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012; 125(25): 31273132. DOI: 10.1161/CIRCULATIONAHA.112.092312
  8. Lumngwena EN, Skatulla S, Blackburn JM, Ntusi NAB. Mechanistic implications of altered protein expression in rheumatic heart disease. Heart Failure Reviews. 2022; 27(1): 357368. DOI: 10.1007/s10741-020-09993-1
  9. Aremu OO, Samuels P, Jermy S, Lumngwena EN, Mutithu D, Cupido BJ, et al. Cardiovascular imaging modalities in the diagnosis and management of rheumatic heart disease. International Journal of Cardiology. 2021; 325: 176185. DOI: 10.1016/j.ijcard.2020.09.049
  10. Gapu P, Bwakura-Dangarembizi M, Kandawasvika G, Kao D, Bannerman C, Hakim J, et al. Rheumatic fever and rheumatic heart disease among children presenting to two referral hospitals in Harare, Zimbabwe. South African Medical Journal. 2015; 105(5): 384. http://www.samj.org.za/index.php/samj/article/view/9076. DOI: 10.7196/SAMJ.9076
  11. Boyarchuk O, Hariyan T, Kovalchuk T. Clinical features of rheumatic heart disease in children and adults in western Ukraine. Bangladesh Journal of Medical Science. 2018; 18(1): 8793. DOI: 10.3329/bjms.v18i1.39556
  12. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, Mcmurray J, et al. Predominance of heart failure in the Heart of Soweto emerging challenges for urban African communities. 2013; 23602367. DOI: 10.1161/CIRCULATIONAHA.108.786244
  13. Essop MR, Peters F. Contemporary issues in rheumatic fever and chronic rheumatic heart disease. Circulation. 2014; 130(24): 21812188. DOI: 10.1161/CIRCULATIONAHA.114.009857
  14. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: Insights from the Heart of Soweto Study. European Heart Journal. 2010; 31(6): 719727. DOI: 10.1093/eurheartj/ehp530
  15. Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Archives of Internal Medicine. 2012; 172(18): 13861394. DOI: 10.1001/archinternmed.2012.3310
  16. Carabello BA. Modern management of mitral stenosis. Circulation. 2005; 112(3): 432437. DOI: 10.1161/CIRCULATIONAHA.104.532498
  17. Riaz BK, Selim S, Karim MN, Chowdhury KN, Chowdhury SH, Rahman MR. Risk factors of rheumatic heart disease in Bangladesh: A case-control study. Journal of Health, Population, and Nutrition. 2013; 31(1): 7077. DOI: 10.3329/jhpn.v31i1.14751
  18. Boyarchuk O, Komorovsky R, Kovalchuk T, Denefil O. Socio-demographic and medical predictors of rheumatic heart disease in a low-risk population. Pediatria Polska. 2018; 93(4): 325330. DOI: 10.5114/polp.2018.77998
  19. Sharma N, Toor D. Impact of socio-economic factors on increased risk and progression of rheumatic heart disease in developing nations. Current Infectious Disease Reports. 2019; 21(6): 21. DOI: 10.1007/s11908-019-0677-6
  20. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014; 129(23): e521e643. DOI: 10.1161/CIR.0000000000000031
  21. Maarman GJ, Shaw J, Allwood B. Pulmonary hypertension in majority countries: Opportunities amidst challenges. Current Opinions in Pulmonary Medicine. 2020; 26(5): 373383. DOI: 10.1097/MCP.0000000000000702
  22. Giannitsioti E, Pefanis A, Gogos C, Lekkou A, Dalekos GN, Gatselis N, et al. Evolution of epidemiological characteristics of infective endocarditis in Greece. International Journal of Infectious Diseases. 2021; 106: 213220. DOI: 10.1016/j.ijid.2021.03.009
  23. Keates AK, Mocumbi AO, Ntsekhe M, Sliwa K, Stewart S. Cardiovascular disease in Africa: Epidemiological profile and challenges. Nature Reviews Cardiology. 2017; 14(5): 273293. DOI: 10.1038/nrcardio.2017.19
  24. Mensah G, Roth G, Sampson U, Moran A, Feigin V, Forouzanfar M, et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: A systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovascular Journal of Africa. 2015; 26(2): S610. DOI: 10.5830/CVJA-2015-036
  25. Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, et al. Valvular manifestations of human immunodeficiency virus infection—results from the prospective, multicenter HIV-HEART study. Journal of Cardiovascular Medicine. 2013; 14(10): 733739. DOI: 10.2459/JCM.0b013e32835dc953
  26. Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and clinical spectrum of associated vasculitides. Current Rheumatology Reports. 2011; 13(6): 506512. DOI: 10.1007/s11926-011-0214-6
  27. Ntsekhe M, Hakim J. Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation. 2005; 112(23): 36023607. DOI: 10.1161/CIRCULATIONAHA.105.549220
  28. Naidoo DP, Shein K. The implications of HIV infection on the management of valvular heart disease in Southern Africa. SA Heart Journal. 2017; 6(2): 6474. DOI: 10.24170/6-2-1993
  29. Schwartz T, Magdi G, Steen TW, Sjaastad I. HIV as a risk factor for cardiac disease in Botswana: A cross-sectional study. International Health. 2012; 4(1): 3037. DOI: 10.1016/j.inhe.2011.12.003
  30. Restrepo CS, Diethelm L, Lemos JA, Velásquez E, Ovella TA, Martinez S, et al. Cardiovascular complications of human immunodeficiency virus infection. RadioGraphics. 2006; 26(1): 213231. DOI: 10.1148/rg.261055058
  31. Barbaro G. HIV-Associated Cardiomyopathy. Herz Kardiovaskuläre Erkrankungen. 2005; 30: 48692. DOI: 10.1007/s00059-005-2728-z
  32. Dzudie A, Dzekem BS, Tchoumi CT, Aminde LN, Mocumbi AO, Abanda M, et al. pulmonary hypertension as seen in a rural area in sub-Saharan Africa: High prevalence, late clinical presentation and a high short-term mortality rate during follow up. Cardiovascular Journal of Africa. 2018; 29(4): 208217. DOI: 10.5830/CVJA-2018-007
  33. Odugbesan JA, Rjoub H. Evaluating HIV/Aids prevalence and sustainable development in sub-Saharan Africa: The role of health expenditure. African Health Sciences. 2020; 20(2): 568578. DOI: 10.4314/ahs.v20i2.4
  34. Meel R, Peters F, Libhaber E, Essop MR. The changing spectrum of rheumatic mitral regurgitation in Soweto, South Africa. Cardiovascular Journal of Africa. 2017; 28(4): 215220. DOI: 10.5830/CVJA-2016-086
  35. Nkoke C, Lekoubou A, Dzudie A, Jingi AM, Kingue S, Menanga A, et al. Echocardiographic pattern of rheumatic valvular disease in a contemporary sub-Saharan African pediatric population: An audit of a major cardiac ultrasound unit in Yaounde, Cameroon. BMC Pediatrics. 2016; 16: 43. DOI: 10.1186/s12887-016-0584-z
  36. Huck DM, Okello E, Mirembe G, Ssinabulya I, Zidar DA, Silverman GJ, et al. Role of natural autoantibodies in Ugandans with rheumatic heart disease and HIV. EBioMedicine. 2016; 5: 161166. DOI: 10.1016/j.ebiom.2016.02.006
  37. Moir S, Fauci AS. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. Journal of Allergy and Clinical Immunology. 2008; 122(1): 1219. DOI: 10.1016/j.jaci.2008.04.034
  38. Koegelenberg CFN. Infective endocarditis in the Western Cape Province of South Africa: A three-year prospective study. QJM: An International Journal of Medicine. 2003; 96(3): 217225. DOI: 10.1093/qjmed/hcg028
  39. Parker A, Koegelenberg CFN, Moolla MS, Louw EH, Mowlana A, Nortjé A, et al. High HIV prevalence in an early cohort of hospital admissions with COVID-19 in Cape Town, South Africa. South African Medical Journal. 2020; 110(10): 982987. DOI: 10.7196/SAMJ.2020.v110i10.15067
  40. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009; 339(7716): 332336. DOI: 10.1136/bmj.b2535
  41. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare. 2015; 13(3): 147153. DOI: 10.1097/XEB.0000000000000054
  42. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. Journal of Epidemiology and Community Health. 2013; 67(11): 974978. DOI: 10.1136/jech-2013-203104
  43. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986; 7(3): 177188. DOI: 10.1016/0197-2456(86)90046-2
  44. Home S. 9.5.3 Strategies for addressing heterogeneity. In: Julian PT, Higgins JPT, Green S (eds.), Cochrane handbook for systematic reviews of interventions; 2015: 56. https://handbook-5-1.cochrane.org/chapter_9/9_5_3_strategies_for_addressing_heterogeneity.htm.
  45. Mesquita ET, Ramos RG, Ferrari AH, Martins W de A, da Cruz GG. Rheumatic heart disease and infective endocarditis in a patient with acquired immunodeficiency syndrome. Arquivos Brasileiros de Cardiologia. 1996; 67(4): 255257. http://europepmc.org/abstract/MED/9181724.
  46. Sathekge M, Stoltz A, Gheysens O. Rheumatic fever: A forgotten but still existing cause of fever of unknown origin detected on FDG PET/CT. Clinical Nuclear Medicine. 2015; 40(3): 250252. DOI: 10.1097/RLU.0000000000000619
  47. Vohra R, Kadam D, Kale N. A case of submitral left ventricular aneurysm (SMA), presenting with acute rheumatic fever with HIV infection. Medical Journal of Dr DY Patil University. 2014; 7(2): 225. DOI: 10.4103/0975-2870.126355
  48. DiCarlo FJ, Anderson DW, Virmani R, Burns W, Macher AM, Rotiguez J, et al. Rheumatic heart disease in a patient with acquired immunodeficiency syndrome. Hum Pathol. 1989; 20(9): 917920. DOI: 10.1016/0046-8177(89)90107-X
  49. Radcliffe KW, McLean KA, Benbow AG. Acute rheumatic fever in human immunodeficiency virus infection. Journal of Infection. 1991; 22(2): 187189. DOI: 10.1016/0163-4453(91)91701-X
  50. Dobe I, Manafe N, Majid N, Zimba I, Manuel B, Mocumbi A. Patterns of cardiovascular risk and disease in HIV-positive adults on anti-retroviral therapy in Mozambique. Cardiovascular Journal of Africa. 2020; 31(4): 190195. DOI: 10.5830/CVJA-2020-007
  51. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. European Heart Journal. 2012; 33(7): 866874. DOI: 10.1093/eurheartj/ehr398
  52. Hovis IW, Namuyonga J, Kisitu GP, Ndagire E, Okello E, Longenecker CT, et al. Decreased prevalence of rheumatic heart disease confirmed among HIV-positive youth. Pediatric Infectious Disease Journal. 2019; 38(4): 406409. DOI: 10.1097/INF.0000000000002161
  53. Gleason B, Mirembe G, Namuyonga J, Okello E, Lwabi P, Lubega I, et al. Brief report: Prevalence of latent rheumatic heart disease among HIV-infected children in Kampala, Uganda. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2016; 71(2): 196199. DOI: 10.1097/QAI.0000000000000827
  54. Manafe N, Ngale A, Biquiza N, Zimba I, Majid N, Mocumbi AO. Need for active cardiovascular screening in HIV-infected children under antiretroviral therapy in Africa. Cardiovascular Diagnosis & Therapy. 2019; 9(1): 6872. DOI: 10.21037/cdt.2018.09.18
  55. Ogunmodede JA, Kolo PM, Katibi IA, Salami AK, Omotoso ABO. Structural echocardiographic abnormalities seen in HIV/AIDS patients are independent of CD4 count. Nigerian Journal of Clinical Practice. 2017; 20(6): 716723. DOI: 10.4103/1119-3077.208954
  56. Mishra TK, Mishra SK, Singh S. Cardiovascular manifestations of people living with HIV/AIDS: Report from a hot spot in eastern India. Indian Heart Journal. 2019; 71(4): 338343. DOI: 10.1016/j.ihj.2019.09.006
  57. Chaudhary S, Sawlani KK, Reddy DH, Yadav SC, Patel ML, Tripathi AK, et al. A study of cardiovascular abnormalities in HIV positive patients in a tertiary care hospital in northern India. Journal of Association of Physicians of India. 2017; 65(December): 2429.
  58. Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. New England Journal of Medicine. 2017; 377(8): 713722. DOI: 10.1056/NEJMoa1603693
  59. Zühlke LJ, Steer AC. Estimates of the global burden of rheumatic heart disease. Global Heart. 2013; 8(3): 189195. DOI: 10.1016/j.gheart.2013.08.008
  60. Adetola Odugbesan J, Rjoub H. Evaluating HIV/AIDS prevalence and sustainable development in sub-Saharan Africa: The role of health expenditure. African Health Sciences. 2020; 20(2): 568578. DOI: 10.4314/ahs.v20i2.4
  61. Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. Journal of the American College of Cardiology. 1994; 24(4): 10251032. DOI: 10.1016/0735-1097(94)90865-6
  62. Barbaro G. Evolution and pathogenesis of the involvement of the cardiovascular system in HIV infection. In: Barbaro G, Boccara F (eds.), Cardiovascular disease in AIDS. Milan: Springer-Verlag; 2005. pp. 115. DOI: 10.1007/88-470-0358-X_1
  63. Currie PF, Goldman JH, Caforio ALP, Jacob AJ, Baig MK, Brettle RP, et al. Cardiac autoimmunity in HIV related heart muscle disease. Heart. 1998; 79(6): 599604. DOI: 10.1136/hrt.79.6.599
  64. Chiowchanwisawakit P, Koolvisoot A, Ratanasuwan W, Suwanagool S. Prevalence of rheumatic disease in HIV infected Thai patients. Journal of the Medical Association of Thailand. 2005; 88(12): 17751781.
  65. Freiberg MS, Chang CC, Kuller LH, Goetz MB, Leaf D, Oursler KA, et al. HIV infection and the risk of acute myocardial infarction. JAMA Internal Medicine. 2013; 173(8): 614622. DOI: 10.1001/jamainternmed.2013.3728
  66. Manga P, McCutcheon K, Tsabedze N, Vachiat A, Zachariah D. HIV and nonischemic heart disease. JACC. 2017; 69(1): 8391. DOI: 10.1016/j.jacc.2016.09.977
  67. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013; 39(4): 633645. DOI: 10.1016/j.immuni.2013.10.001
  68. Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2013; 308(4): 379386. DOI: 10.1001/jama.2012.6698
  69. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G, Giancaspro G, Soldini M, et al. Cardiac involvement in the acquired immunodeficiency syndrome: A multicenter clinical-pathological study. AIDS Research and Human Retroviruses. 1998; 14(12): 10711077. DOI: 10.1089/aid.1998.14.1071
  70. Anderson DW, Virmani R, Reilly JM, O’Leary T, Cunnion RE, Robinowitz M, et al. Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. Journal of the American College of Cardiology. 1988; 11(4): 792799. DOI: 10.1016/0735-1097(88)90213-6
  71. Rerkpattanapipat P, Wongpraparut N, Jacobs LE, Kotler MN. Cardiac manifestations of acquired immunodeficiency syndrome. Archives of Internal Medicine. 2000; 160(5): 602608. DOI: 10.1001/archinte.160.5.602
  72. Longo-Mbenza B, Seghers KV, Phuati M, Nkiabungu Bikangi F, Mubagwa K. Heart involvement and HIV infection in African patients: Determinants of survival. International Journal of Cardiology. 1998; 64(1): 6373. DOI: 10.1016/S0167-5273(97)00321-5
  73. Chong T, Alejo DE, Greene PS, Redmond JM, Sussman MS, Baumgartner WA, et al. Cardiac valve replacement in human immunodeficiency virus–infected patients. Annals of Thoracic Surgery. 2003; 76(2): 478481. DOI: 10.1016/S0003-4975(03)00514-9
  74. Cruz RCC, Cordeiro BS, Santos FDS, Fernandes CR, Gama JMA, Ladeia AMT. Predictors of unfavourable outcomes in children and adolescents submitted to surgical mitral valvuloplasty secondary to chronic rheumatic heart disease. Arquivos Brasileiros de Cardiologia. 2019; 113(4): 748756. DOI: 10.5935/abc.20190184
  75. Munasur M, Naidoo D. Underlying rheumatic disease: An important determinant of outcome in tricuspid valve repair. Journal of Heart Valve Disease. 2016; 25(2): 203210. http://www.ncbi.nlm.nih.gov/pubmed/27989068.
  76. Kim BJ, Ki JH, Moon HD, Jung HS, Choo JS, Chung HC, et al. Long-term outcomes after surgery for rheumatic mitral valve disease: Valve repair versus mechanical valve replacement. European Journal of Cardio-Thoracic Surgery. 2010; 37(5): 10391046. DOI: 10.1016/j.ejcts.2009.11.019
  77. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine. 2006; 12(12): 13651371. DOI: 10.1038/nm1511
  78. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, et al. Letters to the editor. FASEB Journal. 2012; 26(11): 43884389. DOI: 10.1096/fj.12-1103LTR
  79. Pietiäinen M, Liljestrand JM, Kopra E, Pussinen PJ. Mediators between oral dysbiosis and cardiovascular diseases. European Journal of Oral Sciences. 2018; 126(S1): 2636. DOI: 10.1111/eos.12423
  80. Dominici C, Chello M. Impact of human immunodeficiency virus (HIV) infection in patients undergoing cardiac surgery: A systematic review. Reviews in Cardiovascular Medicine. 2020; 21(3): 411. DOI: 10.31083/j.rcm.2020.03.104
  81. Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015; 385(9963): 117171. DOI: 10.1016/S0140-6736(14)61682-2
  82. Filsoufi F, Salzberg SP, Von Harbou KTJ, Neibart E, Adams DH. Excellent outcomes of cardiac surgery in patients infected with HIV in the current era. Clinical Infectious Diseases. 2006; 43(4): 532536. DOI: 10.1086/505977
  83. Nqayana T, Moodley J, Naidoo J. Cardiac diseases in pregnancy. In: Card Jour of Africa [Internet]. Jaypee Brothers Medical Publishers; 2008: 145151. https://www.jaypeedigital.com/book/9789352703920/chapter/ch18.
  84. Gaweł S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiadomości lekarskie. 2004; 57(9–10): 453455.
  85. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases. 2005; 15(4): 316328. DOI: 10.1016/j.numecd.2005.05.003
  86. Watkins DA, Beaton AZ, Carapetis JR, Karthikeyan G, Mayosi BM, Wyber R, et al. Rheumatic heart disease worldwide: JACC scientific expert panel. Journal of the American College of Cardiology. 2018; 72(12): 13971416. DOI: 10.1016/j.jacc.2018.06.063
  87. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. The Lancet. 2005; 366(9480): 155168. DOI: 10.1016/S0140-6736(05)66874-2
  88. Jahagirdar D, Walters MK, Novotney A, Brewer ED, Frank TD, Carter A, et al. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV. 2021; 8: e63351. DOI: 10.1016/S2352-3018(21)00152-1
  89. Robich MP, Schiltz N, Johnston DR, Mick S, Tse W, Koch C, et al. Outcomes of patients with human immunodeficiency virus infection undergoing cardiovascular surgery in the United States. Journal of Thoracic and Cardiovascular Surgery. 2014; 148(6): 30663075. DOI: 10.1016/j.jtcvs.2014.07.074
DOI: https://doi.org/10.5334/gh.1265 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 23, 2022
Accepted on: Aug 22, 2023
Published on: Sep 15, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Evelyn N. Lumngwena, Dipolelo Mokaila, Olukayode Aremu, Patrick DMC Katoto, Jonathan Blackburn, Peter Zilla, Charles Shey Wiysonge, Ntobeko Ntusi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.